inhaled beta-agonists MIGHT increase the risk of MI in COPD patients
There's new concern that inhaled beta-agonists MIGHT increase the risk of MI in COPD patients.
Many COPD patients get albuterol or another inhaled beta-agonist to improve breathing.
But new evidence suggests a higher risk of unstable angina and MI in patients using high doses of inhaled beta-agonists.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote